A real-world pharmacovigilance analysis of omadacycline in FDA adverse event reporting system (FAERS) database
In light of the growing use of omadacycline in clinical practice, routinely reviewing data from the FAERS database for signals of AE can help to ensure patient medication safety and enhance overall medical quality.
Authors
- Xiang Liu (ORCID: https://orcid.org/0009-0004-0904-8067)
- Li Zou (ORCID: https://orcid.org/0000-0002-7715-1603)
- Pei Guo
- Shi Xueping
- Chen Wang (ORCID: https://orcid.org/0009-0004-4302-2565)
Institutions
- Chongqing Medical and Pharmaceutical College (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.3389/fphar.2025.1558868
- Citations
- 4
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 5.23
Funders
- Chongqing Municipal Education Commission